PRCT Q4 2025 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$76M+11.9% YoY

Gross Profit

$46M60.6% margin

Operating Income

-$31M-40.6% margin

Net Income

-$30M-39.1% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

-8.3%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$508M

Total Liabilities

$142M

Stockholders' Equity

$366M

Cash & Equivalents

$287M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$68M	+11.9%
Gross Profit	$46M	$44M	+6.0%
Operating Income	-$31M	-$20M	-57.5%
Net Income	-$30M	-$19M	-58.3%

Geographic Segments

UNITED STATES

$67M100%